Guidance on the Safety of Human Cells, Tissues and Organs for Transplantation Regulations: Testing for infectious diseases
These tables are included for reference only.
For details on testing to assess the suitability of CTO donors, including timeframes, refer to sections 18 to 23 (implementation page) of this guidance document.
Appropriate and effective infectious disease markers | Mandatory | Recommended |
---|---|---|
anti-HIV 1 | yes | n/a |
anti-HIV 2 | yes | n/a |
HBsAg | yes | n/a |
anti-HBc IgG | yes | n/a |
anti-HBc IgM | yes | n/a |
anti-HCV | yes | n/a |
anti-HTLV-I | yes* | n/a |
anti-HTLV-II | yes* | n/a |
syphilis | yes | n/a |
HIV-1 using NAT | yes** | n/a |
HCV using NAT | yes** | n/a |
WNV using NAT | n/a | yes |
*Mandatory for donors of leukocyte-rich tissue and recommended for donors of tissues that are not considered to be leukocyte-rich. **Mandatory for tissue from deceased donors. Not necessary for tissue from living donors if the 180-day quarantine and donor retesting protocol is followed. n/a: not applicable |
Appropriate and effective infectious disease markers | Mandatory | Recommended |
---|---|---|
anti-HIV 1 | yes | n/a |
anti-HIV 2 | yes | n/a |
HBsAg | yes | n/a |
anti-HBc IgG | yes | n/a |
anti-HBc IgM | yes | n/a |
anti-HCV | yes | n/a |
HIV-1 using NAT | yes | n/a |
HCV using NAT | yes | n/a |
WNV using NAT | n/a | yes |
n/a: not applicable |
Appropriate and effective infectious disease markers | Mandatory | Recommended |
---|---|---|
anti-HIV 1 | yes | n/a |
anti-HIV 2 | yes | n/a |
HBsAg | yes | n/a |
anti-HBc IgG | yes | n/a |
anti-HBc IgM | yes | n/a |
anti-HCV | yes | n/a |
anti-HTLV-I | yes | n/a |
anti-HTLV-II | yes | n/a |
toxoplasmosis | yes* | n/a |
syphilis | yes | n/a |
anti-CMV IgG | yes | n/a |
anti-CMV IgM | n/a | yes |
Epstein-Barr virus | yes | n/a |
HIV-1 NAT | n/a | X** |
HCV NAT | n/a | yes** |
WNV using NAT | n/a | yes |
*For heart donors **HIV-1 NAT and HCV NAT are only recommended for living organ donors and high-risk deceased organ donors whose organs will be exceptionally distributed. n/a: not applicable |
Appropriate and effective infectious disease markers | Mandatory | Recommended |
---|---|---|
anti-HIV 1 | yes | n/a |
anti-HIV 2 | yes | n/a |
HBsAg | yes | n/a |
anti-HBc IgG | yes | n/a |
anti-HBc IgM | yes | n/a |
anti-HCV | yes | n/a |
anti-HTLV-I | yes | n/a |
anti-HTLV-II | yes | n/a |
anti-CMV IgG | yes | n/a |
anti-CMV IgM | n/a | yes |
syphilis | yes | n/a |
HIV-1 using NAT | yes* | yes |
HCV using NAT | yes* | yes |
WNV using NAT | yes | n/a |
*Mandatory for banked lymphohematopoietic cell donation (that is, cord blood) only. n/a: not applicable |
Page details
- Date modified: